Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Dystrophies”

2,065 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,065 results

Not applicableActive Not RecruitingNCT05735730
What this trial is testing

Can the Risk for AMD be Modulated?

Who this might be right for
Age-Related Macular Degeneration (ARMD)
Association for Innovation and Biomedical Research on Light and Image 1,800
Large-scale testing (Phase 3)Temporarily pausedNCT00460967
What this trial is testing

Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis

Who this might be right for
Age-Related Maculopathy
OccuLogix 325
Not applicableActive Not RecruitingNCT06048185
What this trial is testing

Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study

Who this might be right for
Stargardt Disease
Nanoscope Therapeutics Inc. 6
Not applicableActive Not RecruitingNCT04065490
What this trial is testing

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)

Who this might be right for
Dry Age-related Macular Degeneration
LumiThera, Inc. 96
Testing effectiveness (Phase 2)Study completedNCT02462889
What this trial is testing

IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD

Who this might be right for
Age-Related Macular Degeneration
Jeffrey S Heier 128
Early research (Phase 1)Looking for participantsNCT06395285
What this trial is testing

Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients

Who this might be right for
ROSAH
Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm) 12
Not applicableStudy completedNCT02395757
What this trial is testing

Microperimetry and Eye Progressing From Stage 3 to Stage 4 Age-related Macular Degeneration (AMD)

Who this might be right for
Stage 3 Age Related Macular Degeneration (AREDS Classification)
Hospices Civils de Lyon 182
Testing effectiveness (Phase 2)Ended earlyNCT00414206
What this trial is testing

Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
CoMentis 343
Large-scale testing (Phase 3)UnknownNCT04572698
What this trial is testing

Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）

Who this might be right for
Age Related Macular Degeneration
Luye Pharma Group Ltd. 416
Early research (Phase 1)Study completedNCT01835015
What this trial is testing

Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Alcon Research 50
Early research (Phase 1)Temporarily pausedNCT02452385
What this trial is testing

Phase 1 Study of CM082 in Patients With wAMD

Who this might be right for
Age-Related Macular Degeneration
AnewPharma 56
Not applicableEnrolling By InvitationNCT07165626
What this trial is testing

Evaluation of Retinal Parameters in Patients With Epiretinal Membrane After Vitrectomy

Who this might be right for
Epiretinal MembraneMacular OedemaMacular Diseases+1 more
Pomeranian Medical University Szczecin 100
Not applicableStudy completedNCT01464710
What this trial is testing

Genetic Assessment of Early to Late Macular Degeneration Study

Who this might be right for
Age-related Macular Degeneration
Henry Ferreyra 170
Testing effectiveness (Phase 2)Ended earlyNCT01603043
What this trial is testing

A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic Atrophy
Alcon Research 10
Not applicableStudy completedNCT01010997
What this trial is testing

Foresee Home for Monitoring Age Related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT01298076
What this trial is testing

Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema

Who this might be right for
Diabetic RetinopathyMacular Edema
University of Sydney 61
Not applicableStudy completedNCT03418220
What this trial is testing

Comparison of Cytokine Profiles in Aqueous Humor of Patients With Age Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration, Age-Related
Hospices Civils de Lyon 82
Large-scale testing (Phase 3)Study completedNCT02374060
What this trial is testing

PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial

Who this might be right for
Macular EdemaUveitis
JHSPH Center for Clinical Trials 192
Not applicableStudy completedNCT00359008
What this trial is testing

PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 336
Early research (Phase 1)UnknownNCT04468997
What this trial is testing

The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 67
Load More Results